StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
QUICKHEAL.NS$174.62-6.13%
Fair $174.62+0.0%

QUICKHEAL.NS

Quick Heal Technologies Limited

Technology / Software - ApplicationNSE

$174.62

-11.40 (-6.13%)

Fairly Valued+0.0%Fair Value $174.62Fund rank 27/100 · Data gapFallback financials|
SA 26/D
F-Score: 3/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-300000.00 · quality 47.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is -2.5%, below the 5% threshold
Thesis & Journal · QUICKHEAL.NSLocal privado en este navegador · Quick Heal Technologies Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.5B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-2.5%

↓

Gross Margin

28.3%

↓

Debt/Equity

0.00

↓
52-Week Range$175
$125$417

TradingView lightweight chart

QUICKHEAL.NS price, volumen y niveles de valoración

Último $174.62Periodo -31.2%
Fair value: $174.62

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-2.1%

FCF CAGR

—

FCF margin

-0.0%

FCF / Net income

0.00x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.61B · net income $-109.3M · FCF $-300000.0

2023-FY → 2026-FY

Gross margin

28.3%-12.7% pts

Operating margin

-16.6%-11.8% pts

Net margin

-4.2%-6.5% pts

FCF margin

-0.0%-9.6% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$2.61B$2.61B$2.80B$2.92B$2.78B
Net Income$-109.3M$-109.3M$50.4M$242.4M$64.0M
EBITDA$-65.4M$-65.4M$141.8M$389.4M$240.1M
EPS-1.98-1.980.914.481.14
Gross Margin28.3%28.3%31.1%40.0%40.9%
Operating Margin-16.6%-16.6%-7.0%1.9%-4.8%
Net Margin-4.2%-4.2%1.8%8.3%2.3%
Balance Sheet
Debt/Equity0.000.000.00——
Current Ratio3.403.40———
Cash Flow
Free Cash Flow$-300000.00$-300000.00$-367.1M$106.3M$267.3M
Returns
ROE-2.5%-2.5%1.1%5.5%1.5%
Valuation
P/E——314.40109.54128.46
EV/EBITDA——110.3067.1533.73
P/B2.212.213.596.071.96
Growth & Yield
Revenue Growth-6.6%-6.6%-4.2%4.9%—
EPS Growth-317.6%-317.6%-79.7%293.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.1%

Total return

-40.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.91 → -1.98

Residual

-40.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-40.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.